LAA - Pilot lung cancer risk assessment

In Latvia, a pilot project for developing lung cancer risk assessment, early diagnosis and forecasting techniques based on large data analysis. Doctors acknowledge that treatment is more effective when it is detected as soon as possible. Over the course of the project, ML is intended to be used to diagnose cancer. In this area, the Latvian Investment and Development Agency (LAA) has approved two strategic commercialisation projects under the “Aid for Development of Technology Transfer System” programme for a total amount of EUR 600 thousand. In the event of successful cooperation, a genomics centre may be developed in Latvia, with the necessary technical and research infrastructure, which, using data stored in the “data lake” (data lake), would be able to achieve European excellence in applied research and services. In turn, the genomics centre would result in new and unique data.